Christopher Swift - May 16, 2025 Form 4 Insider Report for HARTFORD INSURANCE GROUP, INC. (HIG)

Role
Chairman and CEO, Director
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact
Stock symbol
HIG
Transactions as of
May 16, 2025
Transactions value $
-$8,564,719
Form type
4
Date filed
5/19/2025, 04:04 PM
Previous filing
May 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Swift Christopher Chairman and CEO, Director ONE HARTFORD PLAZA, HARTFORD Anthony J. Salerno, Jr., Attorney-in-Fact 2025-05-19 0001349356

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIG Stock Option Options Exercise $0 -98.2K -100% $0.00 0 May 16, 2025 Common Stock 98.2K $43.59 Direct F4
holding HIG Stock Option 303K May 16, 2025 Common Stock 303K $48.89 Direct F5
holding HIG Stock Option 352K May 16, 2025 Common Stock 352K $49.01 Direct F6
holding HIG Stock Option 311K May 16, 2025 Common Stock 311K $51.87 Direct F7
holding HIG Stock Option 285K May 16, 2025 Common Stock 285K $53.81 Direct F8
holding HIG Stock Option 328K May 16, 2025 Common Stock 328K $55.27 Direct F9
holding HIG Stock Option 302K May 16, 2025 Common Stock 302K $69.41 Direct F10
holding HIG Stock Option 249K May 16, 2025 Common Stock 249K $78.28 Direct F11
holding HIG Stock Option 116K May 16, 2025 Common Stock 116K $95.74 Direct F12
holding HIG Stock Option 99.4K May 16, 2025 Common Stock 99.4K $116.41 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 4, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2016 and are scheduled to expire on March 1, 2026.
F2 Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $130.00 - $131.00 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $131.00 - $131.25 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
F5 The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F6 The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F7 The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F8 The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F9 The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F10 The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F11 One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F12 One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F13 One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.